Patients with DM or obesity have increased circulating levels of inflammatory markers including C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and ICAM-1 [44–47]. This evidence concerns the gene IL6 and obesity disorder.